Pharmacological Approaches in Neurofibromatosis Type 1-Associated Nervous System Tumors.

ABSTRACT: Neurofibromatosis type 1 is an autosomal dominant genetic disease and a common tumor predisposition syndrome that affects 1 in 3000 to 4000 patients in the USA. Although studies have been conducted to better understand and manage this disease, the underlying pathogenesis of neurofibromatosis type 1 has not been completely elucidated, and this disease is still associated with significant morbidity and mortality. Treatment options are limited to surgery with chemotherapy for tumors in cases of malignant transformation. In this review, we summarize the advances in the development of targeted pharmacological interventions for neurofibromatosis type 1 and related conditions.

SUBMITTER: Rabab'h O 

PROVIDER: S-EPMC8345673 | biostudies-literature |

REPOSITORIES: biostudies-literature